NCT01651481View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

December 31, 2012

Conditions
Rhinitis
Interventions
DRUG

HCP1102

DRUG

Singulair and Xyzal

Trial Locations (1)

Unknown

Samsung medical center, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01651481 - Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination | Biotech Hunter | Biotech Hunter